Go to main content

Back to integrum.se

SV EN

R5__6572

Press releases

Published: 16 June 2023 Icke-regulatorisk

Integrum appoints Jeffrey S. Zanni as President, U.S.

Published: 8 June 2023 Regulatorisk

Year End Report May 2022 – April 2023: CONTINUING TO BUILD THE COMPANY

Published: 8 June 2023 Regulatorisk

Shirley Ryan AbilityLab receives a USD 8.7 million NIH grant to fund clinical trials including Integrum’s e-OPRA Implant System

Published: 1 June 2023 Icke-regulatorisk

Integrum invites to Open House Event to celebrate its 25-year anniversary

Published: 1 June 2023 Icke-regulatorisk

Integrum and collaboration partners receive SEK 3.2 million in research grant for textile-based HOPE project

Published: 29 May 2023 Icke-regulatorisk

Integrum appoints Supply Chain Manager

Published: 11 May 2023 Icke-regulatorisk

Integrum announces the appointment of Scott Flora as adjunct board membe

Published: 9 May 2023 Icke-regulatorisk

Integrum's CEO Rickard Brånemark holds the keynote lecture at ISPO 2023 in Germany

Published: 3 May 2023 Icke-regulatorisk

Integrum moves into new head office at GoCo Health Innovation Cit

Published: 2 May 2023 Icke-regulatorisk

Integrum announces appointment of Jörgen Svanström as interim CFO

Published: 28 April 2023 Icke-regulatorisk

Integrum is granted patent approval for its OPRA™ Implant System in Australia

Published: 2 March 2023 Icke-regulatorisk

Integrum named to Fast Company’s 2023 List of the World’s Most Innovative Companies

Cookies

This website uses cookiesfor statistics and user experience.